Enhanced Neuromelanin Formation and Dopamine Release via Light and Chemical Therapy ID: 2013-007
Photo by starlineart - stock.adobe.com
Technology Overview
This technology introduces a non-invasive approach to stimulate dopamine release and neuromelanin production in the brain using a combination of short-wavelength blue light and flavones. Unlike traditional methods that rely on electrical stimulation, this technique leverages the natural auto-oxidation process of dopamine in the presence of light, flavones, and iron. Initially tested in rodents, it holds promise for treating conditions associated with dopamine deficiency.
Key Advantages
- Non-invasive compared to electrical stimulation methods
- Utilizes natural biochemical processes for neuromelanin and dopamine production
- Offers a novel approach for treating dopamine-related disorders
- Potential for broader application beyond Parkinson's and addiction treatment
- Supported by preliminary research and a provisional patent
Problems Addressed
- Limitations of current dopamine stimulation methods
- Lack of non-invasive treatments for neuromelanin production enhancement
- Challenges in treating dopamine-related conditions like Parkinson's and addiction
Market Applications
- Treatment of Parkinson's disease
- Therapies for addiction and other dopamine deficiency disorders
- Research tools for studying dopamine and neuromelanin dynamics in the brain
Additional Information
Technology ID: 2013-007
Sell Sheet: Download the Sell Sheet here
Market Analysis: Contact us for a more in-depth market report
Date Published: 13 May, 2025
Connect with the Tech Transfer to:
- Meet with the technology manager
- Receive additional information
- Request a marketing plan report